Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Durable Capital Liquidates Descartes Systems Position: Should Investors Avoid the Stock?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/cddef4ea39fac2ef3d368e725859ba9ef166511f-1401x1251.png?w=1401&h=1251
Durable Capital Liquidates Descartes Systems Position: Should Investors Avoid the Stock?

Durable Capital Partners LP fully exited its position in The Descartes Systems Group (NASDAQ:DSGX), cutting 2,253,704 shares, for an estimated $229.08 million portfolio shift, according to a Nov

TheMotleyFool 
0 05.12.25
Descartes Stock Down 29% in a Year — Is That Why a Major Investor Just Cut Its Stake?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/6f699693a3501babe6eb40aac5d3061bf74bda96-1401x1251.png?w=1401&h=1251
Descartes Stock Down 29% in a Year — Is That Why a Major Investor Just Cut Its Stake?

New York City-based Praesidium Investment Management Company cut its stake in The Descartes Systems Group (NASDAQ:DSGX) by 206,057 shares in the third quarter, according to a November 14 SEC filing.

TheMotleyFool 
0 03.12.25
Cartesian (RNAC) Q2 Revenue Drops 99%
Cartesian (RNAC) Q2 Revenue Drops 99%

Cartesian Therapeutics (NASDAQ:RNAC), a biotechnology company pioneering mRNA cell therapies for autoimmune diseases, The company released its Q2 2025 earnings on August 7, 2025. In the update, the

TheMotleyFool 
0 07.08.25